Brain surgery trial hopes to restore movement in stroke survivors
NCT ID NCT07318714
First seen Jan 11, 2026 · Last updated May 03, 2026 · Updated 21 times
Summary
This study tests a new drug, ASP2246, for adults who have trouble moving after a stroke. It is the first time this drug is used in humans. The study has two parts: first, finding safe doses by giving the drug directly to the brain during surgery; second, comparing the drug to a sham procedure. About 84 people will join, and they will be followed for a year to check safety and any improvement in movement.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Toyama University Hospital
RECRUITINGToyama, Toyama, Japan
Conditions
Explore the condition pages connected to this study.